The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sal'kov V.N.

Nauchnyĭ tsentr nevrologii RAMN, Moskva;
Nauchnyĭ tsentr zdorov'ia deteĭ RAMN, Moskva;
Ivanovskiĭ nauchno-issledovatel'skiĭ institut materinstva i detstva im. V.I. Gorodkova

Voronkov D.N.

FGBU "Nauchnyĭ tsentr nevrologii" RAMN, Moskva

Khacheva K.K.

Research Center of Neurology, Moscow, Russia

Fedotova E.Yu.

Research Center of Neurology, Moscow, Russia

Khudoerkov R.M.

FGBU "Nauchnyĭ tsentr nevrologii" RAMN, Moskva

Illarioshkin S.N.

Nauchnyĭ tsentr nevrologii RAMN

Clinical and morphological analysis of a caseof Parkinson’s disease

Authors:

Sal'kov V.N., Voronkov D.N., Khacheva K.K., Fedotova E.Yu., Khudoerkov R.M., Illarioshkin S.N.

More about the authors

Read: 4834 times


To cite this article:

Sal'kov VN, Voronkov DN, Khacheva KK, Fedotova EYu, Khudoerkov RM, Illarioshkin SN. Clinical and morphological analysis of a caseof Parkinson’s disease. Russian Journal of Archive of Pathology. 2020;82(2):52‑56. (In Russ.)
https://doi.org/10.17116/patol20208202152

Recommended articles:
Quality control of immu­nohistochemical studies: compulsory duty or urgent need?. Russian Journal of Archive of Pathology. 2025;(2):43-52
Pathomorphosis of the Parkinson’s disease against the background of DBS STN. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):21-27
Neuroinflammatory and neurodegenerative aspe­cts of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):102-111
Schi­zophrenic spectrum diso­rders and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):136-141
Art and creativity in Parkinson’s disease: the mysterious effe­cts of dopa­mine. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):13-20
Correlation of motor symptoms and cardiovascular dysfunction in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):59-67

References:

  1. Illarioshkin SN, Slominsky PA, Shadrina MI, Bagyeva GKh, Zagorovskaya TB, Markova ED, Karabanov AV, Poleshchuk VV, Polevaya EV, Fedorova NV, Limborskaya SA, Ivanova-Smolenskaya IA. Heterogeneity of sporadic Parkinson’s disease: molecular approach to solving the problem. Annals of Clinical and Experimental Neurology/Annaly klinicheskoi i eksperimental’noi nevrologii, 2007;1(1):23-31. Accessed August 27, 2019. Available at: https://www.annaly-nevrologii.ru/ (In Russ.)
  2. Levin OS, Fedorova NV. Bolezn’ Parkinsona. M.: MEDpress-inform; 2014. (In Russ.)
  3. Szewczyk-Krolikowski K, Tomlinson P, Nithi K, Wade-Martins R, Talbot K, Ben-Shlomo Y, Hu MT. The influence of age and gender on motor and non-motor features of early Parkinson’s disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord. 2014;20(1):99-105. https://doi.org/10.1016/j.parkreldis.2013.09.025
  4. Titova N, Chaudhuri KR. Nonmotor Parkinson’s and future directions. Int Rev Neurobiol. 2017;134:1493-1505. https://doi.org/10.1016/bs.irn.2017.05.017
  5. Dickson DW. Parkinson’s disease and parkinsonism: neuropathology. Cold Spring Harb Perspect Med. 2012;2(8). pii: a009258. Accessed August 27, 2019. https://doi.org/10.1101/cshperspect.a009258
  6. Jellinger KA. Neuropathology of sporadic Parkinson’s disease: evaluation and changes of concepts. Mov Disord. 2011;27(1):8-30. https://doi.org/10.1002/mds.23795
  7. Braak H, Del Tredici K, Rüb U, de Vos RA, Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24(2):197-211. https://doi.org/10.1016/S0197-4580(02)00065-9
  8. Braak H, Del Tredici K. Neuropathological staging of brain pathology in sporadic Parkinson’s disease: separating the wheat from the chaff. J Parkinsons Dis. 2017;7(suppl 1):71-85. https://doi.org/10.3233/JPD-179001
  9. Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT. Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease. Brain. 2013;136(8):2419-2431. https://doi.org/10.1093/brain/awt192

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.